Lexeo Therapeutics, Inc. (LXEO)
9.51
+0.06
(+0.63%)
USD |
NASDAQ |
Dec 09, 16:00
9.45
-0.06
(-0.63%)
After-Hours: 07:20
Lexeo Therapeutics Total Assets (Quarterly): 143.84M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Anixa Biosciences, Inc. | 17.65M |
| GT Biopharma, Inc. | 4.321M |
| Moleculin Biotech, Inc. | 20.35M |
| Spruce Biosciences, Inc. | 15.31M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 23.01M |
| Shareholders Equity (Quarterly) | 120.83M |
| Debt to Equity Ratio | 0.07 |
| Current Ratio | 7.399 |
| Net Debt Paydown Yield | 0.22% |